%PDF-1.4
%
65 0 obj
<>
endobj
62 0 obj
<>
endobj
123 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-03-05T12:32:17Z
2024-03-29T02:52:18-07:00
QuarkXPressª 4.11: AdobePS 8.6 (219)
2024-03-29T02:52:18-07:00
application/pdf
Heather
2002-580.april
uuid:d5f1fec1-1dd1-11b2-0a00-bd0927fd5800
uuid:d5f1fec3-1dd1-11b2-0a00-6a0000000000
endstream
endobj
51 0 obj
<>
endobj
52 0 obj
<>
endobj
66 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
14 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
25 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
38 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
41 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
44 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
153 0 obj
[157 0 R]
endobj
154 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 57 714.5293 Tm
[(31.)-875.1 (Berard )54.8 (A, Solomon DH, )54.8 (A)74 (vorn J. Patterns of drug use in )]TJ
2.175 -1.25 Td
(rheumatoid arthritis. J Rheumatol 2000;27:1648-55.)Tj
-2.175 -1.25 Td
[(32.)-875.1 (Kremer JM. Combination DMARD therapy for rheumatoid)]TJ
2.175 -1.25 Td
(arthritis. Manag Care 2001;10:10-4.)Tj
-2.175 -1.25 Td
[(33.)-875.1 (V)110.8 (erhoeven )54.8 (AC, Boers M, )17.7 (T)35 (ugwell P)110.7 (. Combination therapy in)]TJ
2.175 -1.25 Td
[(rheumatoid arthritis: updated systematic review)64.8 (. Br J Rheumatol)]TJ
0 Tc 0 Tw 0 -1.25 TD
(1998;37:612-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(34.)-875.1 (Gonzalez-Alvaro I, Hernandez-Garcia C. emAR study)64.8 (. )17.7 (V)110.8 (ariability)]TJ
2.175 -1.25 Td
(in the management of therapeutic resources [Spanish]. In: emAR.)Tj
T*
[(Estudio sobre el manejo de la )54.8 (Artritis Reumatoide. Barcelona:)]TJ
T*
(TINGS Servicios de Comunicacion; 2001:92-128.)Tj
30.825 12.5 Td
[(35.)-875.1 (V)59.8 (illaverde )17.7 (V)128.9 (, Hernandez-Garcia C, Gonzalez-Alvaro I, et al.)]TJ
2.175 -1.25 Td
[(V)110.8 (ariability in the follow-up of patients with rheumatoid arthritis in)]TJ
T*
(Spain [Spanish]. Rev Esp Reumatol 2002;\(in press\).)Tj
-2.175 -1.25 Td
[(36.)-875.1 (De La Mata J, Blanco FJ, Gomez-Reino JJ. Survival analysis of)]TJ
2.175 -1.25 Td
(disease modifying antirheumatic drugs in Spanish rheumatoid)Tj
0 Tc T*
[(arthritis patients. )54.8 (Ann Rheum Dis 1995;54:881-5.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(37.)-875.1 (Maetzel )54.8 (A, )17.7 (W)79.9 (ong )54.8 (A, Strand )17.7 (V)128.9 (,)-0.1 ( )17.7 (T)35 (ugwell P)110.7 (,)-0.1 ( )17.7 (W)79.9 (ells G, Bombardier C.)]TJ
2.175 -1.25 Td
(Meta-analysis of treatment termination rates among rheumatoid)Tj
T*
(arthritis patients receiving disease-modifying anti-rheumatic drugs.)Tj
T*
(Rheumatology Oxford 2000;39:975-81.)Tj
ET
0 0 0 0 scn
429 777 128 -27 re
f*
BT
0 0 0 1 scn
/T1_1 1 Tf
0 Tw 20.37 0 0 21 460.9631 760.6089 Tm
(\002\003\003\002\004\005\006\003\004\006)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/T1_2 1 Tf
0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:4)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(704)Tj
ET
0 0 0 0 scn
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
78 0 obj
<>
endobj
70 0 obj
<>
endobj
69 0 obj
<>
endobj
106 0 obj
<>
endobj
128 0 obj
<>
endobj
68 0 obj
<>
endobj
100 0 obj
<>stream
HU{PSM.Q! ܥv\U:*(XTT#BH# g*UɂEXNkُ6jt|33}8fn8n+7{]P$E&w넳+Xg]n<aiΒjiκXڡH'.܌Zrg)2yٹL 0BS4%J*FJj?L_c`8GKb.l?SbX6cmİ8״LHlVak|)Gf:9Qhg5'KrIE"ޢEw/.XRlvɎ%<[^KO-[u
}hfk廖ۻ99Sx~?¿ſ}%h,JoIo,hQׇƊ6уӏs}>Rx <6h+exR'i8Hh\E%e}S,t8;.5 FW\Qš;GG_TO¦ 8x|1r0ǟ! k[5
q%(⢬B&ʐf(3TAFsI!8F!crybSZ[X"vmצR! ɸF?{H4z\o)NЄmϐ]2ZYOGDkvyoX+߁4URg^3/+7dT*nT>k`9W3o@kA-5:U'h\"fƝ:(:nTxq.osYuWZ9Q4$
Q
ӯljJo־\l;j;5P6o#O j#ɮg&(tօ=t(豏riuP/v8$q҇Yk>25*9C98O[B
FFo9OB!Ⱦ5/ՠ~{PzJAO-msrOCCr⋄Eǵ'gzlVrA;s%?j^?)685|S`2K,_$fU:@G輸ڂZI&Y,HGfExۥ;_rii}k&s2T^)Cnu4g&_y)2"ini;G_RtZ*ȆPA|D?9SȬmAɚ
H'$[]~qVY%+
M^x0"%TK-&)]bu8ke Xk'`3FFIZɕuPq}G3"!ӈVAZQV)L;ӯrY;!}+ݏt$
|`m&r 2ܶ!U,"Ia+aMe۩y!D'ZCuECIgiSq߄V{PSw67TƮ+:SljuV"
Z!`^@B+$@ ! H (JQ*bRu춻U2?7v`w͜};2ͪ[,@8Jv'mȚ@&^UfCIMo(Z/h9/^/.49aA(Ʌ^Sc`eVQcJ3>D$VNsܻ_=#ߊ .jH̍b6QkdPNF8rЯ>a}7k4f^~9JVkVg,[GhnoylMk'j3v "]!UHڐ|^~(FnKg$`}X,vANM[Ldÿ́RocsZm%(q*rP0t4$O0 ӄMAgEJH,?Df%&In#nztpa;8CD_A7,":0|f%d{BR86{}/#]t9A41!QY^>Q{OW<ڝ\EЋ$p3%Poe z4_8Y_`of"28X[o*u@tSh6Mi=3N^嫁.)œc|XPƛOZ~yеLkS-+Ty];΄s>ds3"d7{p֠^1QMAa\) t$i8
!H;j`_<:Hg?6'qY
-m0 e\ꟼ,
jPD"l$0QB'*74F_OP93/t1MFi+ynNztbϳ9]߽|s;VEHm>ךuń19A{$3x{f0Ay
۞{<x_υ>$KUnUBC˗q}1? K~
>e7AWLJ@#"X5D:V]emʶqۣKׅ%Ư<8%J'QsQ:T!{ʵoNGZhzE^0'_l*gL^0=|r]*o͢`;$'VZHvP7gi>%`9٤+gX29eWY8 6GdnzN1ş'k1!qFXhzkNHjRtCGyC]tŮJMHfOO\H6{yGn7O8RPЛCanԼj!V&D7J&z#71
@Ĝj?J,5PWYE7<[7ht%^jZPH%toyd1K?!<2#NK{[5:2mBE,ZL5[&ND1$TG2xg\Ͼ%asT|s
I~8*41IB7WG,U$nai]GC{SaL6qgPˌ τA<5uiHė5o9mmdڜWZ`ɑ 2IĔ[,h]&"dV15r/Ab_*sعs6tJSo8nʽS`Ro"EQE1Y#ڤ{D[e&Ԣ:9GE
:GMɪ"$YY2AxRv_a3$q0j:<:Ky0Lƅ2*I//](w
m-^@{ }ϓntRΖW뜦\,7_6v;+k*%MrU*(l5z/EX+du !Ի8p,V#DIX,k)PH{Rm6IU)'-Kr&Q(Q!y/kLf>MJ.e%%fm%B`Hy5ua9!p6n Rfv3T#R@1@BKB !$7VP
+鶺{؏t:ٿΜs~ϧ7SVٸ)<0:7|hխ!l$y xVݤ2K.nw)Ś#agmen,BڀI~*9ܒ=>3z:߬&J9,pC=?;i$E҇K+Ͻ<"s rUPh&C1S#ɽdpv?AL̫z5y\Ty蛥OQM姩<LQoqMXOguI)|
(Wov^/{wEkP"Z*CÌ}ogWV -7T=y8O=loوr5f>OXzr8+UZN/Fja`uAlSĀSzQ:¡i\nMm7X
"GAq5ݪpq+Z5j!0:!j$ҿoHP/_J>Wց1^@ΏM+?/u_݃PZUۋ\@Oxr(GwM0Ba/!a4+0YB֘\DcVWD82IJ_"ڴR<\O9Txrm\Ȟq@TOPu$ΤJL^(U*a;=آ}ClImTVhJ% k~
G{ryʝyDef*i&i>==&ai2Yv!~Wяډ-nmO8ZP\>h)|]#Yq\TwND!dY*J[^d-/"v(
ɓE/Ps[+RЈ#v.}8LK,TzakslcTU؎~O/ĠkEJZ9E~DWxno;law\]TUXk9OiRỐ8qT8UFc`)uuGR$_#5sl. 7בiuSPuN IX4
+뎵OYSbWKmrʥ(5`qD4U3[Qd5z5swry{3 Εthee%D=+`<~Y\8,NK\ȅׁٛZGRuhKa s$WiQtڨ`Y5{uAqW"!{/9wΆS
{G`7ilYp'0 =R9
endstream
endobj
72 0 obj
<>
endobj
74 0 obj
<>
endobj
71 0 obj
<>stream
H\n0y
/[UcL*El#e۪iwDH ,g[vpkU.!;}|fp0(Fu~ǐN.g߆)FmTkȱw镢na(K1B[yQAWQpN-`l?zE;\tmaЭtI;N:a %lΚK6 a- w(HxX\ j@Ar$< Pq9
Zy.@A.$<*
w (HxX
5Nj
L
giFLF&3/LԶr,#C?<)_
endstream
endobj
73 0 obj
<>stream
H\{PSwo$?W56ܛkݺ>ݪ(Q^iW@ QB#FM@ ! +U]kvv?Ewi?v|g̙s;
P(|}7ǧg
CxYl*lMOu|.\_e]
}?]PVAPJ8h|L'1B/ A\)qG
Ać:!'$
AE\? B`g[3Z.Dſ[i˶/fVIJĕ#JCk`{3
6RAv~%MvIc|Ƙ+=.+sfzR-tƋY'fGV7s1~aioi4\
JGį|[NO-voI4rk@
7JH o@6\O_RfKںUCݚ+QSzMRsP
֒ %;DQht o^W=\Wg23LjB,ɓ$'s8=JOWmP)*R(P(TT! ZblpqA$|CA٬T3ӯE8'Kv'"]v%rjeGvHL
fVl¡V.Tu&jѴhrj*l.fCOp'uA$cx(7;S(O )RY$E+ؔvnpК:.]ZcU־aΨڠhBA\n.>.
?cg%asxSCk5LEgҎ{8-ttX6Ջzc}GGG,#2R52>K{^A ;{Y5nhjmhgwE/`,+N؏PCxha1Ir68MRCC*63Oأ>nHF.b3Y Sc
'xjz%Lw,4Rh{@hڋEr9D\7#")8aH~GKjUIgz\C.Q$M[N"D[|V#K5(y.:?e=k&sKMwbJș &8[zPș瓘-`?]^%V_^^:q;.8*`M*D3WFf69kK;ǝ'~Qےց$W L.AI_+n3?P?@44wZ:wir
$>XPD
%{TQrqqčɑgMUݫ:W%Sojj6[cX_oF2͉H`4^D\9xq,d%!0dVg6[L@6T8t~ф3Xl2:מ܆5O&OAir.'UhtbbKY%8TIVRh-PPnJZ˥ڻM/?ǗVH]6{IV3RAMrkVj]6ͤiQ{#;{`ad3&
XҌIƦcltW?,1t^֜so SU7lW1[_̕=f sGR1$TEke2dG47$[s"<)OBA)#u|%u]:~.賰D: >'[Ke B hhY;s[uӬ^nP?+I0#,>GgEq9N#<@rfp7=WӉ;ͱKQ7ithllF%:!u$J *b=N'Vѯ6
tFvFG;qwS kE[t>mn{۷:{4dOqĀ/
I|2~~mA砳6[
W˾xX :!|=2z\OۮTobDWi4U4PoU A6ҍⷘt4Lra8mU6{H(iUI9ezHCwvqܭ-ku5&مJC-BgѳB ԿݹG[Ke{y YI
Dz^IU6ŖB
YFy)*,
D\W?A(*P,"}q*D&I"ҿg"\?rlj:cjsK/=$j>lC{0Z;et(RJx@LQ2Z[QW1t]<Tqp!|&5/id<
^<J'V i1*+:X~$
*3mvj4N^r($eǞH=#hZ ^OvK.nvoo7ʡa&w(Kkֈ<9%6d~j@2wpjKwkOAW=)_*Mf`q2Nqxܹ7soxF tPр[&x]ڃoO6tjGmI\i
+*FPtu3~U^St8*f죷P5ʍI>P,Cjnw~p2(9݉q:33kv}TsYwA@5
cC_7D8 cͫfCʵ`M9W7eJP?zo0|qc@Ce-tq-/{2`T8]<-.q9r&(g DeXG'Qz*?Ru̜iɰE]ꐾAn2bMa(
.cAOtq>
MgXEҹs
r<.oLS[GXo D종.+]IJ2:zW%j+f?+]yd8
G3LVb%SP*֔ƌn]A>F:;qyޟ(,.esVg64hA͐s.:
Cq兝frs]tx$:6r"xy4jәKjgJp9Djbx;!YmsY*4VmXZK8
SY__[a3{,=htLH:%!?PjG-&X[^]e:{ҙt7݉Y0;3]W5EMטӀSdxjj+vѮ+@|H[ydu(pi&=zUMdE⨺H4Oګ5
שn 3͌xu]L81qcy0%$VI H`px:+qQBIڦ?6dL$ͤ{|};G[}-UL9)cXL.v]"[0+O0kq+F]ӱ^ͥ5;n5Rਢ3~^')NGt5bT\H$KD*Hq2Tjy]Hx̫@r@ۃgz]6b98Y6 ~Mdlt1@go@Kq\~O1#ꜺllMnd?6LFGӛRD/+
i
TK:!eOf*zFc&FSCNL£
THc95.Aɜrq=pj z3oH6+Ud~qm lN@vVv5,"9>}-
"L,Kʫ+%+S@eІ-=Hdy)I"<zDT%W4RlRcY[
OPЕqEypΚm´Lp2&ut)9-i/zKꤜ|TiڮL͔J*O.Jk:Е(9'̕ջ`/}S[ :uTHiw~e8wl1qvUtm
nyS7j uBiD`<<>71
:F=cPX60bDߚ@H?
Ο蛃/[3
mRH0[Ů@!ZWUQF[g"瑯wAHz
T.̅ed8R{$)槗E$xL4b4`E>nNgn ˖LAxx'9ʬ(d)
t#s+fW0?[TBؚnoo8;lgXzF(qW776 n8